Photoactive electrospun cellulose acetate/polyethylene oxide/methylene blue and trilayered cellulose acetate/polyethylene oxide/silk fibroin/ciprofloxacin nanofibers for chronic wound healing

Int J Biol Macromol. 2021 Dec 15;193(Pt B):1752-1766. doi: 10.1016/j.ijbiomac.2021.11.012. Epub 2021 Nov 12.

Abstract

This study aimed to synthesize cellulose acetate (CA)-based electrospun nanofibers as drug delivery dressings for chronic wound healing. For the first time, CA was blended with polyethylene oxide (PEO) using acetone and formic acid. Methylene blue (MB) was incorporated into monolayered random CA/PEO nanofibers. They had a diameter of 400-600 nm, were hydrophilic, and generated reactive oxygen species upon irradiation. Thus, they mediated antimicrobial photodynamic inactivation (aPDI) against isolated biofilm-forming Staphylococcus aureus, Klebsiella pneumoniae, and Pseudomonas aeruginosa. Bacterial survival, biofilm mass, and produced pyocyanin of the treated groups declined by 90%, 80%, and 3 folds, respectively. On the other hand, ciprofloxacin (Cipro) was loaded into an innovative trilayered aligned nanofiber consisting of CA/PEO surrounding a blank layer of silk fibroin. Cipro and MB release followed the Korsmeyer-Peppas model. An infected diabetic wound mouse model was established and treated with either MB-aPDI or Cipro. A combined therapy group of MB-aPDI followed by Cipro was included. The combined therapy showed significantly better results than monotherapies delineated by elevation in re-epithelization, collagen deposition, CD34, and TGF-β expression, along with a decline in CD95+ cells. This study deduced that drug-loaded CA electrospun nanofibers might be exploited in multimodal chronic wound healing.

Keywords: Antimicrobial photodynamic inactivation (aPDI); Chronic wound healing; Electrospun nanofibers.

MeSH terms

  • Animals
  • Anti-Bacterial Agents* / chemistry
  • Anti-Bacterial Agents* / pharmacology
  • Bacteria / growth & development*
  • Cellulose / analogs & derivatives*
  • Cellulose / chemistry
  • Cellulose / pharmacology
  • Ciprofloxacin* / chemistry
  • Ciprofloxacin* / pharmacology
  • Diabetes Mellitus, Experimental / drug therapy*
  • Diabetes Mellitus, Experimental / metabolism
  • Diabetes Mellitus, Experimental / microbiology
  • Fibroins* / chemistry
  • Fibroins* / pharmacology
  • Male
  • Methylene Blue* / chemistry
  • Methylene Blue* / pharmacology
  • Mice
  • Nanofibers* / chemistry
  • Nanofibers* / therapeutic use
  • Polyethylene Glycols* / chemistry
  • Polyethylene Glycols* / pharmacology
  • Wound Healing / drug effects*

Substances

  • Anti-Bacterial Agents
  • acetylcellulose
  • Polyethylene Glycols
  • Ciprofloxacin
  • Cellulose
  • Fibroins
  • Methylene Blue